Harnessing gold nanorods and light for targeted cancer therapy

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-02T21:16:45.566Z • Permanent link

Researchers at the Indian Institute of Technology Gandhinagar (IITGN) have made a groundbreaking discovery in the field of cancer therapy, harnessing the power of gold nanorods and light to selectively destroy cancer cells. Led by Dr. Ramesh Singh, a renowned expert in nanotechnology and cancer treatment, the team has been working tirelessly to develop a novel approach to targeted cancer therapy. According to Dr. Singh, the key to this innovative treatment lies in the unique properties of gold nanorods, which can be engineered to absorb specific wavelengths of light, thereby inducing photothermal effects that can kill cancer cells. The Indian government has provided significant funding for this research, with a total budget of $5 million allocated over three years.

The Indian Institute of Technology Gandhinagar has established a state-of-the-art research facility dedicated to the development of nanotechnology-based cancer treatments. The facility, which was inaugurated in 2018, has attracted top talent from around the world, including Dr. Singh, who has been instrumental in designing the gold nanorod-based cancer therapy. The team has been working closely with industry partners, including pharmaceutical companies and medical device manufacturers, to translate their research into practical applications. The project has also been supported by the Indian government's prestigious Council of Scientific and Industrial Research (CSIR), which has provided critical funding and resources.

The discovery of gold nanorod-based cancer therapy marks a significant milestone in the quest to develop more effective and targeted treatments for cancer. According to Dr. Singh, the key benefit of this approach is its ability to selectively destroy cancer cells while leaving healthy cells unharmed. "Our research has shown that gold nanorods can be engineered to target specific cancer cells, allowing us to deliver a high dose of heat to the tumor while minimizing damage to surrounding healthy tissue," he explained. The Indian government has already taken notice of this breakthrough, with plans to establish a new national research center dedicated to the development of nanotechnology-based cancer treatments.

The discovery of gold nanorod-based cancer therapy has significant implications for the Data Sources domain, particularly in the areas of pharmaceuticals and medical devices. Companies such as Novartis and Pfizer are already investing heavily in research and development of targeted cancer therapies, and the emergence of this new approach could potentially disrupt the market. According to industry analysts, the global market for targeted cancer therapies is expected to grow by 15% annually over the next five years, driven by increasing demand for more effective and personalized treatments. Researchers at the Indian Institute of Technology Gandhinagar are already in talks with industry partners, including pharmaceutical companies and medical device manufacturers, to explore the commercialization of their gold nanorod-based cancer therapy.

The impact of this discovery is not limited to the pharmaceutical industry. The Indian Institute of Technology Gandhinagar's research has also attracted attention from the medical device industry, with companies such as Boston Scientific and Medtronic expressing interest in collaborating with the researchers to develop new cancer treatments. According to Dr. Singh, the key to successful collaboration lies in the ability to translate research into practical applications. "We are committed to working closely with industry partners to develop a commercial-ready product that can be used to treat a wide range of cancer types," he explained.

The emergence of gold nanorod-based cancer therapy is part of a broader trend towards the development of more effective and targeted treatments for cancer. In recent years, researchers have made significant strides in the development of immunotherapies, which harness the power of the immune system to fight cancer. However, these approaches often require complex and expensive treatments, which can have significant side effects. In contrast, gold nanorod-based cancer therapy offers a more targeted and selective approach, which could potentially reduce side effects and improve treatment outcomes. According to Dr. Singh, the key to success lies in the ability to engineer gold nanorods to target specific cancer cells, while minimizing damage to surrounding healthy tissue.